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IL-17 Expression in Human Herpetic Stromal Keratitis:
Modulatory Effects on Chemokine Production by Corneal
Fibroblasts1
Jeroen Maertzdorf, Albert D. M. E. Osterhaus, and Georges M. G. M. Verjans2
Herpetic stromal keratitis (HSK) is an immunopathologic disease triggered by infection of the cornea with HSV. Key events in
HSK involve the interaction between cornea-infiltrating inflammatory cells and resident cells. This interaction, in which macro-
phages, producing IL-1 and TNF-, and IFN--producing Th1 cells play a crucial role, results in the local secretion of immune-
modulatory factors and a major influx of neutrophils causing corneal lesions and blindness. The Th1-derived cytokine IL-17 has
been shown to play an important role in several inflammatory diseases characterized by a massive infiltration of neutrophils into
inflamed tissue. Here we show that IL-17 is expressed in corneas from patients with HSK and that the IL-17R is constitutively
expressed by human corneal fibroblasts (HCF). IL-17 exhibited a strong synergistic effect with TNF- on the induction of IL-6 and
IL-8 secretion by cultured HCF. Secreted IL-8 in these cultures had a strong chemotactic effect on neutrophils. IL-17 also
enhanced TNF-- and IFN--induced secretion of macrophage-inflammatory proteins 1 and 3, while inhibiting the induced
secretion of RANTES. Furthermore, considerable levels of IFN--inducible protein 10 and matrix metalloproteinase 1 were
measured in stimulated HCF cultures, while the constitutive secretion of monocyte chemotactic protein 1 remained unaffected. The
data presented suggest that IL-17 may play an important role in the induction and/or perpetuation of the immunopathologic
processes in human HSK by modulating the secretion of proinflammatory and neutrophil chemotactic factors by corneal resident
fibroblasts. The Journal of Immunology, 2002, 169: 5897–5903.
H erpes simplex virus infection of the cornea can lead tothe development of a chronic inflammatory disease ofthe cornea called herpetic stromal keratitis (HSK),3 a
leading cause of nontraumatic blindness in developed countries
(1). HSK is considered to result from an immunopathologic pro-
cess in the cornea involving both innate and adaptive immune
responses to the replicating virus (2). Solid support for this view-
point comes from studies in experimental mouse models. In im-
munocompetent mice the disease is associated with a biphasic cel-
lular infiltrate in the corneal stroma. In the preclinical phase, when
HSV-1 replicates in the corneal epithelium, neutrophils invade the
underlying corneal stroma (3). This transient response, triggered
by replicating virus (4, 5), is thought to control HSV replication
and limit viral spread into peripheral tissues (6, 7). During the
second phase, i.e., the clinical phase, a second wave of inflamma-
tory cells, predominantly consisting of neutrophils, infiltrates the
corneal stroma (8). An essential factor for the development of HSK
is the involvement of IL-2- and IFN--secreting CD4 T cells,
orchestrating the extravasation and activation of neutrophils. These
neutrophils are considered to be directly involved in corneal de-
struction (9–11). Additionally, Langerhans cells (LC) and macro-
phages, secreting the proinflammatory cytokines IL-1 and TNF-,
are essential mediators (12–15).
Extensive studies in murine models of HSK have provided in-
sight into the roles multiple chemokines play in the development
of the disease (5, 8, 16, 17). These studies demonstrated the tem-
poral expression of chemokines like IL-8, RANTES, macrophage-
inflammatory protein (MIP)-1, monocyte chemotactic protein
(MCP)-1, and IFN--inducible protein (IP)-10 in affected murine
corneas. These chemokines are likely to contribute to the recruit-
ment and activation of lymphocytes, dendritic cells, and neutro-
phils, initiating the clinical phase of HSK. Although the cellular
source of the chemokines involved in HSK remains ill defined,
they may be produced by infiltrating inflammatory cells and/or
resident corneal cells. Several studies have implied that the inter-
action with inflammatory cells mainly involves fibroblasts within
the corneal stromal layer. The stromal cell layer of the cornea is
made up of fibroblasts providing mechanical strength to the cornea
by supporting a framework of extracellular matrix. Large numbers
of IFN-- and TNF--producing cells have been observed in the
stromal layer of HSV-infected murine corneas but not in the epi-
thelial or endothelial layers (18, 19). This corresponds to the lo-
cation of neutrophils that mainly infiltrate the stromal fibroblast
cell layer of the cornea. Similarly, the induction of IL-8, which
exhibits neutrophil chemotactic properties, has been shown to be
associated with HSV replication in corneal fibroblasts but not in
epithelial cells (20).
Evidence is accumulating that activated tissue resident cells, in-
cluding fibroblasts, are involved in modulating local immune re-
sponses by expressing adhesion molecules and secreting regula-
tory factors like cytokines and chemokines. Macrophage-derived
cytokines like IL-1 and TNF-, and Th1 cytokines like IFN-,
have been shown to activate mesenchymal cells (21–26). Interest-
ingly, another recently described Th1 cytokine, IL-17, can exert
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strong synergistic and/or antagonistic effects with the aforemen-
tioned proinflammatory cytokines. These effects include the mod-
ulation of MHC and adhesion molecules and the induction of a
variety of cytokines and chemokines by mesenchymal cells (21–
24, 27–30). This modulatory effect of IL-17 could therefore have
an indirect but profound effect on the recruitment and activation of
different inflammatory cells into the corneal stroma during human
HSK. To address this issue, we analyzed the induction of the cy-
tokine IL-6, various chemokines, and matrix metalloproteinase
(MMP)-1 by human corneal fibroblasts (HCF) upon stimulation
with IL-1, TNF-, and IFN-. The combinative effect of IL-17
with these cytokines on HCF activation was emphasized.
Our data show that IL-17 is expressed in corneas of HSK pa-
tients and has a regulatory effect on the induction of immune-
modulatory factors by cytokine-stimulated HCF. These results
indicate that the interaction of IL-17 with HCF may play a signif-
icant role in the initiation and perpetuation of the inflammatory
processes in human HSK.
Materials and Methods
Cytokines and mAbs
Human recombinant IL-1, IL-17, TNF-, and IFN- were obtained from
PeproTech (London, U.K.). For blocking experiments, neutralizing mAbs
directed to human IL-17 (R&D Systems, Abingdon, U.K.), IL-8, and iso-
type-matched control mAbs were used (PeproTech).
Human intracorneal T cell lines (TCL) and HCF cultures
The generation of HSV-specific TCL used in this study, obtained from
affected corneas of two HSK patients, has been described previously (31).
To determine IL-17 mRNA expression, TCL were either left unstimulated
or stimulated with PMA (50 ng/ml) and ionomycin (500 ng/ml). Primary
HCF cultures were generated from three individual donor corneas that had
been rejected for transplantation use due to low endothelial cell counts, and
from one transplanted HSK-diseased cornea. The central part of each cor-
nea was finely minced and digested with collagenase essentially as de-
scribed elsewhere (31). Adherent cells were cultured in six-well plates in
medium consisting of a 1:1 ratio of DMEM and Ham F12 nutrient mixture
(Life Technologies, Breda, The Netherlands) supplemented with 10% FCS
and antibiotics. HCF cultures, with a fibroblast-like morphology, were
grown in bulk in 162-cm2 flasks and cryopreserved. All cells stained pos-
itive for vimentin by immunofluorescence staining, whereas almost no re-
activity was found for both the acidic and basic subfamilies of cytokeratin
(data not shown), indicating that HCF cultures were not contaminated with
corneal epithelial or endothelial cells. Third- or fourth-passage corneal fi-
broblasts were used in all experiments. For cytokine stimulation experi-
ments, HCF from donor corneas were grown in medium of DMEM and
Ham F12 with 10% FCS and antibiotics. At confluence, medium was re-
placed with a serum-free medium consisting of DMEM supplemented with
2 mM L-glutamine, 20 g/ml cholesterol, and 0.3% BSA (all obtained from
Sigma-Aldrich, St. Louis, MO). HCF were left for 5 days on serum-free
medium before stimulation with cytokines. Serum-free medium was used
to maintain a more native biosynthetic phenotype and appearance (32) and
to reduce background levels of cytokine and chemokine production (data
not shown). Stimulatory cytokines were added to the HCF cultures and
supernatants were collected after 48 h. All tested stimulatory conditions
were repeated in at least eight individual experiments unless stated other-
wise. For blocking experiments, the stimulating mixture of cytokines was
preincubated with a neutralizing anti-IL-17 mAb (10 g/ml) at room tem-
perature 30 min before addition to the cell culture. Inhibition of cytokine
and chemokine expression was induced by pretreatment of HCF cultures
with 10 ng/ml of the anti-inflammatory drug dexamethasone (Sigma-
Aldrich) for 2 h.
RNA isolation and RT-PCR analyses
Total cellular RNA was extracted from human HSK corneas, cultured
HCF, or intracorneal TCL with TRIzol reagent (Life Technologies) ac-
cording to the manufacturer’s protocol. The cornea buttons analyzed were
obtained from three patients with a fulminant HSV-induced necrotizing
stromal keratitis after therapeutic penetrating keratoplasty. HSK classifi-
cation and disease status were defined on the basis of clinical criteria (33).
None of the patients were treated with steroids. For RT-PCR analyses, total
RNA was converted into cDNA using oligo(dT) and reverse transcriptase.
The following synthetic oligonucleotides were used for PCR amplification:
for IL-17 amplification, primers 5-ATCTCCACCGCAATGAGGAC-3
and 5-GTGGACAATCGGGGTGACAC-3 (232-bp amplicon); for
IL-17R, primers 5-CTAAACTGCACGGTCAAGAAT-3 and 5-CTG
AGCTCATGCATGGCGTGG-3 (456-bp amplicon). As an internal con-
trol for the amount of cDNA, the GAPDH gene was amplified with primers
5-GGTGAAGGTCGGAGTCAACG-3 and 5-CAAAGTTGTCATGGAT
GACC-3 (496-bp amplicon). Amplification was performed in standard
PCR buffer with 1 U AmpliTaq Gold DNA polymerase (PerkinElmer, Gro-
ningen, The Netherlands), 200 M dNTPs, and 25 pmol of each primer in
a total volume of 50 l. DNA amplification was started with a 5-min
incubation at 95°C, followed by 35 cycles of denaturation at 95°C for 1
min, annealing at 50°C for 1 min, and extension at 72°C for 1 min. The
final extension was at 72°C for 7 min. PCR products were separated on a
2% agarose gel and visualized by ethidium bromide staining. Southern
blotting and labeling with a specific 32P-labeled oligonucleotide probe was
performed to confirm the specificity of the amplicons.
ELISA
Culture supernatants from corneal fibroblasts stimulated for 48 h, referred
to as conditioned medium, were harvested and cleared of cellular debris by
centrifugation. Secretion levels of IL-6, IL-8, RANTES, MIP-3, IP-10,
and MMP-1 were measured with commercially available ELISA kits
(R&D Systems). MIP-1 content was measured in an ELISA using a coat-
ing mAb, recombinant human MIP-1 as a standard, and an HRP-conju-
gated detection mAb (R&D Systems). The amount of MCP-1 in culture
supernatants was determined using a commercially available ELISA kit
obtained from BioSource (Nivelles, Belgium). The detection limits of the
ELISA were as follows: IL-6,0.7 pg/ml; IL-8,10 pg/ml; RANTES,8
pg/ml; MIP-3, 0.9 pg/ml; IP-10, 4.5 pg/ml; MMP-1, 21 pg/ml; MIP-
1, 10 pg/ml; and MCP-1, 20 pg/ml.
Neutrophil chemotaxis
Polymorph mononuclear cells (PMN) were isolated from fresh peripheral
blood of healthy, adult volunteers using Polymorph Prep (Nycomed, Oslo,
Norway) and residual erythrocytes were lysed. To analyze the chemotactic
activity of conditioned medium of HCF, PMN were brought to a final
concentration of 2  106 cells/ml in serum-free medium. The chemotaxis
assay was performed in a 24-well Transwell system (Costar, Badhoeve-
dorp, The Netherlands). The bottom wells of the chamber were filled with
100 l of recombinant human IL-8 (10 ng/ml) as a positive control for
neutrophil chemotaxis, the control solution, or conditioned medium from
stimulated HCF cultures, diluted 1/10 in serum-free medium. The upper
wells, holding a polycarbonate filter with a pore size of 3 m, were placed
on top and filled with 150 l of neutrophil suspension. The Transwell
system was incubated in humidified air with 5% CO2 at 37°C for 45 min,
and the number of cells that had migrated through the filter into the bottom
well were counted. Inhibition of IL-8-mediated neutrophil recruitment in-
volved a preincubation of the conditioned medium with 10 g/ml anti-IL-8
mAb 30 min before the experiment at room temperature. As a control,
conditioned medium was incubated under similar conditions with an irrel-
evant isotype-matched control mAb.
Statistical analysis
Results are expressed as the mean  SD. The statistical significance of the
modulatory effect of IL-17 on cytokine-treated was determined by the
Mann-Whitney U test. Differences resulting in p values 0.05 were con-
sidered to be statistically significant.
Results
IL-17 expression in corneas and intracorneal TCL obtained
from HSK patients
Whereas the normal healthy cornea is essentially devoid of T cells,
HSK is considered an immunopathologic disease orchestrated by
corneal-infiltrating CD4 Th1 cells secreting IL-2 and IFN- (9–
11). To assess the possible role of the Th1 cytokine IL-17 in hu-
man HSK, the expression of IL-17 mRNA was determined in cor-
neas from three patients with fulminant HSK who underwent
corneal transplantation to restore sight. IL-17 transcripts could be
detected in all HSK corneas, while no IL-17 was detected in con-
trol corneas (Fig. 1A). Mitogenic stimulation of two intracorneal
TCL generated from corneas of two other HSK patients induced
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IL-17 mRNA expression. This demonstrates that corneal-infiltrat-
ing T cells, at least in part, are able to express IL-17 mRNA upon
activation (Fig. 1B).
HCF constitutively express the IL-17R
The keratogenic properties of Th1 cytokines in HSK may in part
be due to their modulatory effect on corneal resident cells. Corne-
al-infiltrating T cells are mainly observed in the corneal stroma,
suggesting an interaction between T cells and corneal fibroblasts
by means of direct cell-cell contact or soluble factors like IL-17.
To evaluate whether corneal fibroblasts express the IL-17R, RT-
PCR was performed on RNA extracted from three primary HCF
cultures. Two primary HCF cultures had been generated from two
healthy donor corneas and one from a transplanted HSK-diseased
cornea. RT-PCR analysis showed that HCF expressed IL-17R
mRNA (Fig. 2).
Synergistic effect of IL-17 on TNF--induced IL-6 and IL-8
secretion by HCF
Studies in HSK mouse models have shown a strong induction of
IL-6 and IL-8 after HSV-1 infection of the cornea (5, 20). By
mimicking the inflammatory situation in the corneal stroma during
HSK development in vitro, we determined the modulatory effect of
IL-17 (100 ng/ml) on IL-1 (100 ng/ml), TNF- (50 ng/ml), and
IFN- (100 U/ml) to induce secretion of IL-6 and IL-8 by HCF.
Optimal concentrations of stimulatory cytokines had been deter-
mined in preliminary experiments (data not shown).
HCF showed a low level of background secretion of both IL-6
and IL-8, while stimulation with IL-17 or IFN- alone or in com-
bination did not show any considerable increase in either IL-6 or
IL-8 levels (Fig. 3). However, stimulation of HCF with IL-1 or
TNF- did have a clear stimulatory effect on the secretion of both
factors. Although IL-17 itself had no effect, incubation of HCF
with combinations of stimulating cytokines showed that it had a
synergistic effect on the TNF-- and TNF-/IFN--induced secre-
tion of both IL-6 and IL-8. This synergistic effect was almost com-
pletely neutralized by preincubating the stimulating cytokine mix-
ture with an anti-IL-17 mAb, but not with an isotype-matched
control mAb (Fig. 3). Furthermore, a 2-h pretreatment of HCF with
dexamethasone, an immunosuppressive drug commonly used in
treating human HSK, almost completely abolished the induced se-
cretion of IL-6 and IL-8 (Fig. 3).
Modulatory effect of IL-17 on HCF secretion of chemokines
and MMP-1
In addition to IL-6 and IL-8, several other chemokines are ex-
pressed in affected corneas and are assumed to play a critical role
in the development of HSK (5, 8). Because HCF are a probable
cellular source for these chemokines, we also analyzed the effects
of stimulation with IL-1, TNF-, IL-17, and IFN- on chemokine
production (including MCP-1, RANTES, MIP-1, MIP-3, and
IP-10) and MMP-1 by HCF.
The observation by Tumpey et al. (34) that MIP-1 knockout
mice fail to develop HSK suggests that this chemokine is a key
FIGURE 1. Expression of IL-17 mRNA expression in human HSK cor-
neas and intraocular TCL analyzed by RT-PCR and Southern blotting. A,
RNA was isolated from corneas from three patients transplanted during
active HSK (lanes 1–3) and from three healthy donor control corneas
(lanes 4–6). B, HSV-1-specific intracorneal TCL from two other HSK
patients were cultured and RNA from a total of 106 mitogen-stimulated
(P/I) or nonstimulated () cells was extracted for analysis. , Positive
control on RNA from mitogen-stimulated PBMC.
FIGURE 2. Corneal stromal fibroblasts constitutively express IL-17R
mRNA. Corneal fibroblasts were cultured from two individual healthy do-
nor corneas (lanes 1 and 2) and one transplanted non-HSK cornea (lane 3).
RNA was isolated from 106 cells from each culture and assayed for IL-17R
mRNA expression by RT-PCR and Southern blotting., Water control;,
positive control.
FIGURE 3. IL-6 and IL-8 secretion by stimulated HCF. Cultured HCF
were stimulated for 48 h with the cytokines indicated and IL-6 and IL-8
levels in conditioned medium were determined by ELISA. Cytokine mix-
tures were preincubated 30 min before an anti-IL-17 mAb or an isotype-
matched control mAb (“isotype”) was added to the cell cultures to block
IL-17 activity. “Dexa” indicates a 2-h preincubation of the cells with dexa-
methasone (10 ng/ml). Results are expressed as the mean  SD of four
separate experiments. The statistical significance of the modulatory effect
of IL-17 on cytokine-treated was determined by the Mann-Whitney U test.
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factor in the development of the disease. MIP-1 secretion by
HCF, although in low amounts (up to 30 pg/ml), was observed
solely upon costimulation of IL-17 with TNF-, IFN-, or both
cytokines combined (Fig. 4). Whereas MIP-1 is mainly chemo-
tactic for neutrophils, MIP-3 is a powerful chemoattractant for
LC precursors (35). Both IL-1 and TNF- induced the secretion
of MIP-3 by HCF, whereas neither IL-17 nor IFN- stimulated
MIP-3 secretion (Fig. 4). IL-17 showed a clear synergistic effect
with TNF- and TNF-/IFN- on MIP-3 secretion by HCF, but
not with IL-1 or IFN-.
Intracorneal expression of RANTES and IP-10 is restricted to
the preclinical phase of HSK. Both these chemokines are known to
induce T cell migration (36). Secretion of RANTES could only be
induced by TNF-, whereas IP-10 production was augmented by
TNF- and IFN- (Fig. 4). Stimulation of HCF with TNF- and
IFN- combined had a synergistic effect on the secretion of both
RANTES and IP-10. IL-17 showed a remarkable inhibition on the
secretion of RANTES by HCF upon stimulation with TNF- and
TNF-/IFN-, while IP-10 production was only slightly inhibited
by IL-17 (Fig. 4).
Although the role of MCP-1 is not clear at this point, it has been
reported to play a role in CD4 T cell recruitment and appears to
be rapidly up-regulated and persistently expressed in HSV-1-in-
fected corneas (5). In our experiments, HCF constitutively secreted
MCP-1, and no evident changes were observed by incubation with
stimulatory cytokines (Fig. 4). Although MMP-1 is not a chemo-
kine, it was included in this study because MMP-1 is known to
degrade fibrilar collagens (37), an essential component of the cor-
neal stroma. HCF showed a constitutive secretion of MMP-1,
which was not affected by IFN-. Compared with the mild induc-
tion by IL-17, IL-1 and TNF- induced a strong enhancement of
MMP-1 secretion. Interestingly, IL-17 had a synergistic effect with
IFN- on MMP-1 secretion while showing a slight inhibitory effect
in combination with IL-1 or TNF- (Fig. 4).
HCF induce neutrophil recruitment through IL-8 release
Chemokines expressed within HSV-1-infected corneas are be-
lieved to induce the corneal infiltration of neutrophils involved in
the development of corneal lesions (3, 5, 8, 16, 17). To test the
PMN chemotactic properties of chemokines secreted by HCF, con-
ditioned medium from control and cytokine-stimulated HCF cul-
tures were tested in a neutrophil chemotaxis assay. Conditioned
medium from HCF stimulated with the combination of IL-17,
TNF-, and IFN- was used because it contained the highest levels
of IL-8 and MIP-1 (see Figs. 3 and 4), both potent PMN che-
moattractants. rIL-8 (10 ng/ml) was used as a positive control,
while fresh serum-free medium served as background control.
Compared with the medium control, conditioned medium from
stimulated HCF induced a strong migration of PMN. This effect
could be blocked by pretreatment of the conditioned medium with
a neutralizing anti-IL-8 mAb 30 min before the experiment (Fig.
5). Conditioned medium from nonstimulated HCF caused a mild
migration of PMN, probably due to a low level of background
production of IL-8 in these cultures (see Fig. 3).
Discussion
HSK is an HSV-induced corneal disease characterized by complex
interactions between infiltrating inflammatory cells and corneal
resident cells. These cellular interactions are assumed to result in
the induction and perpetuation of a chronic inflammatory process
resulting in corneal damage (2, 3, 7, 8). Stimulation of mesenchy-
mal cells with proinflammatory cytokines, of macrophage/mono-
cyte (IL-1 and TNF-) or Th1 cell (IFN-) origin, has previously
been shown to activate and modulate the secretion of chemokines
(21–26), suggesting a role of resident cells such as fibroblasts in
the recruitment and activation of inflammatory cells to sites of
inflammation. Furthermore, recent observations have shown that
FIGURE 4. Chemokine and MMP-1 secretion by stimulated HCF. Cultured HCF were stimulated for 48 h with the indicated cytokines and chemokine
and MMP-1 levels in conditioned medium were determined by standard ELISA. Results are expressed as the mean  SD of four separate experiments.
The statistical significance of the modulatory effect of IL-17 on cytokine-treated was determined by the Mann-Whitney U test. N.D., Not done.
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activation of resident cells can be heavily modulated by the Th1-
derived cytokine IL-17 (21–24, 27–30). Accordingly, the potential
interactive role of IL-17 and corneal fibroblasts in the induction
and perpetuation of inflammatory processes in human HSK was
hypothesized.
The expression and pathogenic properties of IL-1, TNF-, and
IFN- in HSK have been extensively studied in the experimental
HSK mouse model. These proinflammatory cytokines probably do
not have a direct immunopathologic effect by recruiting and stim-
ulating inflammatory cells, but rather exert their effects through
interaction with corneal resident cells in an autocrine or paracrine
fashion. IL-17 is secreted by activated CD4 T cells, mainly Th0
and Th1 (27), and exhibits pleiotropic biological activities on var-
ious human tissue resident cells including fibroblasts. IL-17 shares
mainly properties with IL-1 and TNF- in that these three cyto-
kines activate the transcription factor NF-B in a variety of cell
types and all stimulate secretion of proinflammatory factors in
mesenchymal cells (27). The present study shows IL-17 expression
in affected corneas of patients with fulminant HSK, whereas no IL-17
expression was detectable in control corneas. Mitogenic stimulation
of intracorneal TCL obtained from corneas of HSK patients induced
IL-17 mRNA expression. The HCF constitutively expressed the IL-
17R, consistent with its broad tissue distribution (38).
IL-17 indirectly stimulates granulopoiesis both in vitro (27) and
in vivo (39), and has also previously been marked in playing an
important role in the pathogenesis of other immune-mediated diseases
associated with a massive infiltration of neutrophils into inflamed tis-
sues (40–45). The functional relevance of IL-17 signaling in host
defense has recently been demonstrated in an experimental model of
Klebsiella pneumoniae lung infection in IL-17R knockout mice (46).
IL-17R signaling appeared to be critical for the local induction of
G-CSF and MIP-2 and subsequent PMN recruitment into the al-
veolar space. The murine C-X-C chemokines MIP-2 and KC, ho-
mologs of human IL-8, have also been associated with the devel-
opment of experimental murine HSK (5). Neutralization of MIP-2
decreased corneal PMN infiltration and significantly reduced cor-
neal pathology, demonstrating that MIP-2 is the major chemokine
that attracts PMN into the HSV-1-infected cornea in mice (17).
Interestingly, in our experiments, conditioned medium from HCF
stimulated with the combination of TNF-, IFN-, and IL-17 in-
duced chemotaxis of PMN in vitro (Fig. 5). Despite the presence
of multiple other chemokines in these conditioned media, this che-
motactic activity on PMN was mainly induced by IL-8, because
preincubation of conditioned medium with a neutralizing IL-8
mAb almost completely abrogated PMN migration.
The data presented here demonstrate that cytokine-stimulated
HCF secrete chemokines associated with HSK. Chemokine secre-
tion was differentially regulated by Th1 cell- and macrophage/
monocyte-derived cytokines. Compared with IFN- and IL-17,
IL-1 and TNF- were more effective in stimulating HCF to se-
crete IL-6, IL-8, MIP-3, and MMP-1. Whereas simultaneous
treatment with TNF- and IFN- induced significant secretion of
RANTES and IP-10 by HCF, no detectable amounts of MIP-1
were observed upon stimulation with these cytokines. However,
neither Th1 cell-derived nor macrophage/monocyte-derived cyto-
kine seemed to significantly alter the constitutive expression of
MCP-1.
The induced secretion of IL-6 and IL-8 by HCF stimulated with
either IL-1 or TNF- was consistent with observations previ-
ously described (47, 48). Similarly, induction of IL-6 secretion
upon stimulation with IL-1 or TNF- has also recently been ob-
served in myofibroblast cells (49). In addition, such cells do not
secrete any MIP-1 upon stimulation with IL-1 or TNF- (26),
comparable with our results. However, in comparison with another
report on chemokine production by HCF (50), we observed some
contradiction in the induction of RANTES and MCP-1 secretion
by treatment of HCF with IL-1 or TNF-. In this report stimulation
of HCF with IL-1 or TNF- resulted in increased levels of RAN-
TES and MCP-1 production. In contrast, stimulation of HCF in our
experiments with IL-1 did not induce secretion of detectable
amounts of RANTES, nor did IL-1 or TNF- significantly alter
MCP-1 secretion. Although the different effects of IL-1 and
IL-1 on HCF are understandable, the differential effect of TNF-
on MCP-1 production might be related to the usage of serum in
cell cultures that might contain costimulatory factors that were
absent in our experiments. In a recent report about rheumatoid
arthritis in man, RANTES and MCP-1 have been shown to induce
IL-6 and IL-8 (51). These chemokines thus appear not to solely
play a role in inflammatory cell migration, but also to be involved
in the activation of synoviocytes. Consequently, the secretion of
the chemokines detected in conditioned medium of cytokine-stim-
ulated HCF may only in part be directly induced by the cytokines
added.
As in human HSK corneas, IL-17 expression has been observed
in other inflamed tissues, such as the lungs in asthma (52) and the
synovium in arthritis (53). IL-17 exerts a modulatory effect on
IL-1-, TNF--, and IFN--induced chemokine secretion by human
mesenchymal cells (21–24, 27–30). Furthermore, IL-17 has been
described to stimulate the secretion of IL-1 and TNF- by mac-
rophages (54). In our experiments, IL-17 had a synergistic effect
on TNF--induced HCF secretion of IL-6, IL-8, and MIP-3,
which was similar to observations by others (23, 25, 27, 52, 55).
Additionally, a synergistic effect was observed for IL-17 with
TNF- and IFN- on the induction of MIP-1, whereas, similar to
findings in keratinocytes (21), IL-17 antagonized TNF-- and/or
IFN--induced secretion of RANTES. However, in contrast with
some of these reports (21, 27), no synergistic effect of IL-17 with
FIGURE 5. Conditioned medium from stimulated HCF cultures induces
neutrophil migration. Serum-free medium served as the background control
and recombinant human IL-8 (10 ng/ml) was used as a positive control for
neutrophil migration. “Nonstimulated” indicates conditioned medium from
cells incubated with serum-free medium alone; stimulated conditioned me-
dium was obtained from cells stimulated with IL-17, TNF-, and IFN-
simultaneously. Blocking neutrophil migration was achieved by a 30-min
preincubation of the conditioned medium with an anti-IL-8 mAb (10 g/
ml). Filled and shaded bars represent conditioned media from two different
stimulation experiments (mean  SD) and are representative of four indi-
vidual experiments. The statistical significance of the different chemotactic
activity of cytokine-stimulated vs nonstimulated HCF culture conditioned
media was determined by the Mann-Whitney U test.
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IL-1 or IFN- was observed, which might be a cell type-specific
phenomenon.
As its name suggests, IP-10 is known to be induced by IFN-,
as was also observed in our experiments. Strikingly, IP-10 secre-
tion by HCF was strongly increased upon costimulation with both
IFN- and TNF-, which is in accordance with a previous report
(56). Whereas a previous report (57) showed no significant stim-
ulatory effect of IL-17 on IP-10 induction in keratinocytes, our
results showed a slight inhibitory effect of IL-17 on IP-10 secretion
by HCF. Secretion of IL-6 and IL-8, induced by HCF stimulation
with a combination of IL-17, TNF-, and IFN-—resulting in the
highest secretion levels (Fig. 3)—was inhibited by pretreatment
with an anti-IL-17 mAb to levels similar to those of TNF- plus
IFN-, demonstrating the specific modulatory effect of IL-17. Glu-
cocorticoids such as dexamethasone are widely used in the treat-
ment of corneal inflammatory diseases. The data presented here
show that secretion of IL-6 and IL-8 by cytokine-stimulated HCF
can be completely blocked by pretreatment with dexamethasone.
This is compatible with the idea that the beneficial effects of glu-
cocorticoids in clinical practice are due to inhibition of exagger-
ated cytokine production. This effect of glucocorticoids is medi-
ated by their antagonistic action on transcription factors such as
NF-B, which are required for cytokine transcription (58).
The collection of chemokines found to be secreted by HCF upon
cytokine stimulation exhibits a broad range of leukocyte-recruiting
and -activating potentials. These activities include the migration
and activation of T and NK cells (e.g., RANTES, MCP-1, MIP-3,
and IP-10), LC (e.g., MIP-3), macrophages/monocytes (e.g.,
MCP-1), and PMN (e.g., IL-8 and MIP-1). Studies on expression
profiles of different chemokines in the HSK mouse models have
shown that most proinflammatory cytokines and chemokines are
expressed throughout both the preclinical and clinical phase of
HSK (8). Exceptions to this are the chemokine MIP-1, which was
detected only during the clinical phase, and the chemokines IP-10
and RANTES, which can only be detected early after HSV-1 in-
fection of the cornea, but not during the clinical phase of the dis-
ease (8). Remarkably, in the present study IL-17 exerted a strong
stimulatory signal on the induction of IL-8, MIP-1, and MIP-3,
whereas it inhibited the secretion of RANTES and, to a lesser
extent, IP-10. This IL-17-specific inhibitory effect on RANTES
and IP-10 secretion might reflect a down-regulatory signal by ac-
tivated T cells to limit the recruitment of additional T lymphocytes,
and corresponds with the transient detection of these chemokines
in the cornea early after infection. In contrast, increased secretion
of IL-8 and MIP-1 would create an inflammatory environment in
the corneal stroma with a high potential for PMN extravasation
and activation, where they directly or indirectly cause tissue dam-
age. Although MMP-1 is not a chemokine, its secretion in the
corneal stroma might explain some clinical aspects of HSK. As
described previously, IL-1 and TNF- augmented secretion of
MMP-1 in human fibroblasts (59). MMP-1 degrades structural
type I and type II collagen, and its production in the corneal stroma
during HSK might thus contribute to the development of corneal
lesions. Accordingly, IL-17 has previously been implicated in sy-
novium matrix destruction in rheumatoid arthritis by similar
modes of action (60).
In conclusion, our study shows the ability of cytokine-stimu-
lated HCF to secrete inflammatory mediators that are potentially
involved in the immunopathogenesis of HSK. The Th1 cytokine
IL-17, expressed in human HSK corneas, modulated these re-
sponses in a synergistic or antagonistic fashion. We speculate that
during the development of HSK, in addition to corneal-infiltrating
cells, corneal fibroblasts are an important cellular source of proin-
flammatory cytokines and chemokines. Among these is IL-8,
which primarily mediates the extravasation and activation of
pathogenic PMN into the cornea. Furthermore, our results suggest
that IL-17 might be an important player in the immune activation
of HCF. Future studies in murine models might elucidate any po-
tential role of IL-17 in the inflammatory processes leading to HSK.
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